RETROPHIN

Serial Number 88304121
606

Registration Progress

Application Filed
Feb 15, 2019
Under Examination
Feb 4, 2020
Approved for Publication
Dec 10, 2019
Published for Opposition
Dec 10, 2019
Registered

Trademark Image

RETROPHIN

Basic Information

Serial Number
88304121
Filing Date
February 15, 2019
Published for Opposition
December 10, 2019
Abandonment Date
March 8, 2021
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 8, 2021
Classes
005

Rights Holder

TRAVERE THERAPEUTICS, INC.

03
Address
3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO, CA 92130

Ownership History

Retrophin, Inc.

Original Applicant
03
San Diego, CA

Retrophin, Inc.

Owner at Publication
03
San Diego, CA

TRAVERE THERAPEUTICS, INC.

New Owner After Publication #1
03
SAN DIEGO, CA

Legal Representation

Attorney
Hayley J. Talbert

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

25 events
Date Code Type Description Documents
Mar 8, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 8, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 23, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 21, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 17, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 4, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 10, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 10, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 1, 2019 ALIE A ASSIGNED TO LIE Loading...
Oct 26, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 25, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 23, 2019 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 23, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 23, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 29, 2019 CPRA R PRIORITY ACTION WRITTEN Loading...
Apr 29, 2019 GPRA F PRIORITY ACTION E-MAILED Loading...
Apr 29, 2019 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Apr 26, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of liver disease and monogenic disease; pharmaceutical preparations for the treatment of disease, namely, kidney disease, metabolic disorders, or central nervous system disorders
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a white pathway through a center of a circle, the pathway dividing individual triangles in varying shades of blue on the left side of the pathway and varying shades of blue and green on the right side of the pathway, centered above the word "RETROPHIN" in black.
Color Claim
The color(s) blue, green, white and black is/are claimed as a feature of the mark.

Classification

International Classes
005